- 中文名稱
B型腦鈉肽 EIA試劑盒
- 英文名字
- BNP Fragment EIA Kit
- 供應(yīng)商
- Biomedica Immunoassays
- 產(chǎn)品貨號(hào)
- BI-20852W
- 產(chǎn)品報(bào)價(jià)
- ¥12x8tests

- 產(chǎn)品說明書
- 點(diǎn)擊查看
- 購(gòu)買方式
- 90%產(chǎn)品中國(guó)有現(xiàn)貨庫(kù)存。銀行轉(zhuǎn)賬、電匯、支票、現(xiàn)金,在線支付寶及網(wǎng)銀支付,或直接與我們電話聯(lián)系400-6800-868
- 產(chǎn)品新聞

- 背景資料
- The natriuretic peptides are members of a family of structurally similar but genetically distinct peptide hormones, consisting of atrial-, brain-, and C-type (ANP, BNP, and CNP, respectively). ANP and BNP preferentially bind to a membrane-bound guanylyl cyclase (GC) receptor called GC-A or NPR1, whereas CNP is the physiological ligand for GC-B (NPR2). The natriuretic peptides play an important role in the regulation of cardiovascular and renal homeostasis and in the regulation of fatty acid metabolism and body weight.
BNP is mainly expressed by ventricular myocardium in response to volume overload and increased filling pressure. BNP has a cleavable signal sequence. Mature BNP consists of 108 amino acids (proBNP or BNP-108), and undergoes cleavage resulting in physiologically active BNP-32 and additional C-terminal fragments (cf. http://www.uniprot.org/uniprot/P16860#PRO_0000001532), along with a physiologically inactive N-terminal peptide comprising amino acids 1-76 (NT-proBNP), which is further degraded proteolytically.
- 產(chǎn)品描述
- Method
Competitive enzyme immunoassay (EIA), HRP/TMB, 12×8-well detachable strips
Sample type
Serum, EDTA plasma, hepar?n plasma, citrate plasma
Product volume
30 μl / well
Assay time
Overnight (18 – 25 h) / 20 min
Sensitivity
171 pmol/l (=1449 pg/ml)
Standard range
0 – 6,400 pmol/l (0 – 54,237 pg/ml)
Conversion factor
1 pmol/l = 8.475 pg/ml (MW: 8.475 kDa)
Specificity
Endogenous and recombinant human NT-proBNP.
Precision
In-between-run (n=8): ≤ 7 % CV
Within-run (n=3): ≤ 3 % CV
Cross-reactivity
The assay does not cross react with rat, mouse, dog, or cat samples.
- 產(chǎn)品特點(diǎn)
- 保存建議
- +4°C
- 其他
- Biomedica Immunoassay(bmgrp)公司成立于1988年, 總部位于奧地利維也納,主要致力于研究、開發(fā)和生產(chǎn)基于ELISA方法用于臨床前研究相關(guān)標(biāo)記物檢測(cè)的工具。迄今為止Biomedica Immunoassay公司在心血管檢測(cè)及骨代謝檢測(cè)領(lǐng)域開發(fā)了一系列特色ELISA檢測(cè)試劑盒,Biomedica Immunoassay的生產(chǎn)過程符合GMP/GLP指南,并符合ISO 9001:2015管理體系,有CE認(rèn)證。Biomedica Immunoassay的產(chǎn)品根據(jù)FDA, EMEA和ICH指南進(jìn)行驗(yàn)證,并具有驗(yàn)證報(bào)告。
-

- 注意
-
該頁面的中文產(chǎn)品信息的翻譯,僅供參考。準(zhǔn)確的產(chǎn)品信息請(qǐng)以廠家的英文說明書為準(zhǔn)。下單前,請(qǐng)瀏覽說明書確認(rèn)。
-